메뉴 건너뛰기




Volumn 55, Issue 4, 2011, Pages 949-950

Safe drugs to fight mutant protein overload and alpha-1-antitrypsin deficiency

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; CEFTRIAXONE; GLIAL FIBRILLARY ACIDIC PROTEIN; MUTANT PROTEIN;

EID: 80052944868     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2011.03.033     Document Type: Letter
Times cited : (4)

References (10)
  • 1
    • 79954867271 scopus 로고    scopus 로고
    • Drug enhanced autophagy to fight mutant protein overload
    • M. Mehrpour, and P. Codogno Drug enhanced autophagy to fight mutant protein overload J Hepatol 54 2011 1066 1068
    • (2011) J Hepatol , vol.54 , pp. 1066-1068
    • Mehrpour, M.1    Codogno, P.2
  • 2
    • 77954597127 scopus 로고    scopus 로고
    • An autophagy-enhancing drug promotes degradation of mutant alpha1-antitrypsin Z and reduces hepatic fibrosis
    • T. Hidvegi, M. Ewing, P. Hale, C. Dippold, C. Beckett, and C. Kemp An autophagy-enhancing drug promotes degradation of mutant alpha1-antitrypsin Z and reduces hepatic fibrosis Science 329 2010 229 232
    • (2010) Science , vol.329 , pp. 229-232
    • Hidvegi, T.1    Ewing, M.2    Hale, P.3    Dippold, C.4    Beckett, C.5    Kemp, C.6
  • 4
    • 0024418209 scopus 로고
    • Treatment of cerebellar tremors with carbamazepine: A controlled trial with long-term follow-up
    • G.P. Sechi, M. Zuddas, M. Piredda, V. Agnetti, G. Sau, and M.L. Piras Treatment of cerebellar tremors with carbamazepine: a controlled trial with long-term follow-up Neurology 39 1989 1113 1115 (Pubitemid 19217487)
    • (1989) Neurology , vol.39 , Issue.8 , pp. 1113-1115
    • Sechi, G.P.1    Zuddas, M.2    Piredda, M.3    Agnetti, V.4    Sau, G.5    Piras, M.L.6    Tanca, S.7    Rosati, G.8
  • 5
    • 0020646939 scopus 로고
    • Carbamazepine versus diphenyldantoin in the treatment of myotonia
    • G.P. Sechi, S. Traccis, L. Durelli, F. Monaco, and R. Mutani Carbamazepine versus diphenylhydantoin in the treatment of myotonia Eur Neurol 22 1983 113 118 (Pubitemid 13148247)
    • (1983) European Neurology , vol.22 , Issue.2 , pp. 113-118
    • Sechi, G.P.1    Traccis, S.2    Durelli, L.3
  • 6
    • 2542598418 scopus 로고    scopus 로고
    • Carbamazepine. Adverse effects
    • R.H. Levy, R.H. Mattson, B.S. Meldrum, E. Perucca, 5th ed. Lippincott Williams and Wilkins Philadelphia
    • G.L. Holmes Carbamazepine. Adverse effects R.H. Levy, R.H. Mattson, B.S. Meldrum, E. Perucca, Antiepileptic drugs 5th ed. 2002 Lippincott Williams and Wilkins Philadelphia 285 297
    • (2002) Antiepileptic Drugs , pp. 285-297
    • Holmes, G.L.1
  • 7
    • 0026686095 scopus 로고
    • Acute toxic reaction to carbamazepine: Clinical effects and serum concentrations
    • J. Tibbals Acute toxic reaction to carbamazepine: clinical effects and serum concentrations J Pediatr 121 1992 295 299
    • (1992) J Pediatr , vol.121 , pp. 295-299
    • Tibbals, J.1
  • 8
    • 0034863166 scopus 로고    scopus 로고
    • COPD: Management of acute exacerbations and chronic stable disease
    • M.H. Hunter, and D.E. King COPD: management of acute exacerbations and chronic stable disease Am Fam Physician 64 2001 603 613
    • (2001) Am Fam Physician , vol.64 , pp. 603-613
    • Hunter, M.H.1    King, D.E.2
  • 9
    • 77953812401 scopus 로고    scopus 로고
    • In vitro treatments with ceftriaxone promote elimination of mutant glial fibrillary acidic protein and transcription down-regulation
    • T. Bachetti, E. Di Zanni, P. Balbi, P. Bocca, I. Prigione, and G.A. Deiana In vitro treatments with ceftriaxone promote elimination of mutant glial fibrillary acidic protein and transcription down-regulation Exp Cell Res 316 2010 2152 2165
    • (2010) Exp Cell Res , vol.316 , pp. 2152-2165
    • Bachetti, T.1    Di Zanni, E.2    Balbi, P.3    Bocca, P.4    Prigione, I.5    Deiana, G.A.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.